Legislature(2017 - 2018)BUTROVICH 205

02/08/2017 01:30 PM HEALTH & SOCIAL SERVICES

Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.

Download Mp3. <- Right click and save file as

Audio Topic
01:31:19 PM Start
01:31:46 PM SB20
02:21:52 PM Adjourn
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
Heard & Held
-- Public Testimony --
          SB 20-LIST U-47700 AS A CONTROLLED SUBSTANCE                                                                      
1:31:46 PM                                                                                                                    
CHAIR WILSON announced the consideration of SB 20.                                                                              
1:32:15 PM                                                                                                                    
SENATOR KEVIN MEYER, sponsor of  SB 20, Alaska State Legislature,                                                               
Juneau, Alaska, set forth that  SB 20 would classify "U-47700," a                                                               
synthetic opioid commonly known as  "Pink" or "U4," as a Schedule                                                               
IA controlled  substance. He  noted that  U-47700 is  eight times                                                               
more powerful than  heroin. He detailed that  research on U-47700                                                               
was started  in the  1970s and patented,  but never  approved for                                                               
human testing or consumption.                                                                                                   
He  said currently  there is  a demand  for opioids.  He revealed                                                               
that labs  in China are busy  making U-47700 and selling  them in                                                               
great quantities  online. He warned  that U-47700 is  very deadly                                                               
and  noted  that  the  national-enforcement  agency  reported  45                                                               
fatalities  thus  far  linked  to  the drug  since  2015  with  3                                                               
confirmed deaths  in Alaska. He  said the federal  government has                                                               
issued a temporary  placement for U-47700 into Schedule  I due to                                                               
the eminent hazard to public safety.                                                                                            
He stated that  everyone is painfully aware of  the opioid crisis                                                               
happening  not  only  nationwide,  but  in  Alaska  as  well.  He                                                               
remarked that  he does not  think a  day goes by  without hearing                                                               
about somebody's  house or  car getting  broke into,  or somebody                                                               
getting held  up so that  people can  get money to  support their                                                               
opioid habit.                                                                                                                   
He urged  the committee to pass  SB 20 and classify  U-47700 as a                                                               
Schedule IA substance so that  law enforcement can go after those                                                               
who  are selling,  using, purchasing,  possessing, manufacturing,                                                               
and transporting  the synthetic  opioid in  Alaska. He  set forth                                                               
that his  preference is to go  after those who purchase  in large                                                               
quantities for the  purposes of selling, but the  bill would also                                                               
allow those who possess and use the drug to be charged.                                                                         
1:35:30 PM                                                                                                                    
SENATOR VON  IMHOF thanked  Senator Meyer  for bringing  the bill                                                               
forward. She  pointed out that  a slight chemical change  and the                                                               
drug  is no  longer identified  as  U-47700. She  asked how  much                                                               
flexibility is allowed in a  drug's composition for its statutory                                                               
identification as U-47700 to continue.                                                                                          
SENATOR MEYER  noted that Senator von  Imhof's question addresses                                                               
an ongoing  frustration. He related  that he has brought  many of                                                               
synthetic drug bills forward  that addressed synthetic marijuana,                                                               
also known  as "Spice," and  synthetic cocaine, which  is derived                                                               
from  bath  salts.  He  remarked   that  the  impression  is  the                                                               
Legislature is constantly chasing  its tail because chemicals are                                                               
simply changed once laws on  synthetic drugs are tightened up. He                                                               
insisted that the Legislature keep  "chasing its tail" because he                                                               
noted  that  changing  chemical   compounds  takes  a  while.  He                                                               
admitted  that he  did  not know  how  much chemical  flexibility                                                               
there  was in  the  state's regulations.  He  suggested that  Dr.                                                               
Butler address Senator von Imhof's question.                                                                                    
1:37:01 PM                                                                                                                    
CHRISTINE  MARASIGAN, Staff,  Senator Kevin  Meyer, Alaska  State                                                               
Legislature, Juneau, Alaska, recommended  that Mr. Charles Foster                                                               
with the  Scientific Crime Detection  Laboratory -  Department of                                                               
Public Safety address Senator von Imhof's question as well.                                                                     
SENATOR  VON  IMHOF pointed  out  that  U-47700 was  created  and                                                               
patented  by a  doctor  in  1976. She  surmised  that the  drug's                                                               
chemical composition  was posted with  the patent office  and was                                                               
readily accessible on the internet.  She asked if there have been                                                               
efforts to  redact portions  of patented  chemicals to  avoid the                                                               
ability for drugs to be copied.                                                                                                 
MS. MARASIGAN  replied that patents  are public  information that                                                               
is not exact.  She noted that redacting  information may actually                                                               
harm  people  because  labs  may produce  riskier  drugs  due  to                                                               
partial information. She revealed  that labs were also disguising                                                               
copied drugs and selling them as something else.                                                                                
1:39:39 PM                                                                                                                    
CHARLES FOSTER, Chemistry  Supervisor, Scientific Crime Detection                                                               
Laboratory,  Alaska  Department   of  Public  Safety,  Anchorage,                                                               
Alaska, explained that  U-47700 is specific to  only one chemical                                                               
structure and no other analogs of similar chemicals.                                                                            
SENATOR BEGICH  asked what the  level of use  of Pink was  in the                                                               
1:41:11 PM                                                                                                                    
DR.  JAY  BUTLER, Chief  Medical  Officer,  Alaska Department  of                                                               
Health  and  Social Services,  Juneau,  Alaska,  opined that  the                                                               
state is  seeing the "tip  of the iceberg" regarding  U-47700. He                                                               
revealed  that  three-overdose  cases have  been  identified  and                                                               
occurred in different parts of  the state which suggests that the                                                               
drug is fairly prevalent.                                                                                                       
SENATOR BEGICH  asked if there has  ever been an attempt  made to                                                               
pass legislation that also included  derivatives of drugs like U-                                                               
DR.  BUTLER  replied that  there  has  been some  legislation  in                                                               
Texas,  but  the legal  analysis  continues.  He noted  that  the                                                               
federal  government  approaches   the  situation  with  emergency                                                               
regulatory authority  and that  was the way  U-47700 ended  up on                                                               
the  federal controlled  substances  list. He  noted that  Alaska                                                               
does not  have emergency regulatory  authority, but an  option to                                                               
consider  to make  the state  more agile.  He concurred  with Mr.                                                               
Foster that U-47700 is a specific chemical structure.                                                                           
1:44:59 PM                                                                                                                    
SENATOR  MICCICHE noted  that the  United  Nations Commission  on                                                               
Narcotic  Drugs estimates  that new  psychoactive substances  are                                                               
emerging  globally  at  an  average   rate  of  one-per-week.  He                                                               
inquired if  there is a better  way to go to  either an automatic                                                               
adherence to the  federal Schedule I which  does include U-47700,                                                               
or  to include  verbiage  about  all non-prescriptions  synthetic                                                               
opioids.  He  pointed  out  that  Senator  Meyer  referenced  the                                                               
chasing  around of  Spice  for  years and  opined  that a  better                                                               
catchall  may  be to  include  the  verbiage on  non-prescription                                                               
synthetic opioids.                                                                                                              
DR. BUTLER agreed that what the  state currently has is not agile                                                               
enough  to even  begin  to  keep pace  with  the  ability of  the                                                               
chemists.  He concurred  that Senator  Micciche's approach  would                                                               
certainly  be   another  viable  option,  but   deferred  to  his                                                               
colleagues in law and public safety  who actually have to use the                                                               
drug laws for prosecution purposes.                                                                                             
SENATOR  MICCICHE  asked  Mr.  Foster  to  address  his  question                                                               
regarding  a   catchall  for   non-prescription  synthetic-opioid                                                               
MR.  FOSTER   replied  that  the  current   law  for  substituted                                                               
cathinones is  similar to Senator  Micciche's inquiry.  He opined                                                               
that the law  for substituted cathinones works as  a larger "net"                                                               
for catching a lot of new  compounds, but the difficult part is a                                                               
pretty  good  knowledge of  chemistry  is  required to  interpret                                                               
whether or  not a compound is  indeed fitting what is  written in                                                               
1:47:52 PM                                                                                                                    
SENATOR MICCICHE  remarked that there  has to be a  better system                                                               
to  address   drugs  rather  than   naming  each   substance.  He                                                               
reiterated that new drugs are  emerging globally on an average of                                                               
CHAIR WILSON replied that he agreed with Senator Micciche.                                                                      
SENATOR GIESSEL pointed out that  the bill addresses Schedule IA,                                                               
which  means Alaska's  scheduling  of drugs  are referenced.  She                                                               
detailed  that  Schedule I  drugs  are  very dangerous,  have  no                                                               
therapeutic use, and have a high  risk of side effects. She noted                                                               
that two  drugs, fentanyl and  methadone, are listed  as Schedule                                                               
IA in Alaska, but federal law  are Schedule II for the same drugs                                                               
and are thus  prescribable by a clinician with a  DEA number. She                                                               
continued as follows:                                                                                                           
     So this bill  refers to a slightly  different list than                                                                    
     perhaps you are  thinking of in federal  law, so that's                                                                    
     just a  nuance here. I  agree with Senator  Micciche, a                                                                    
     more nimble  way to  take care of  this kind  of stuff,                                                                    
     these  illegal  drugs, but  this  is  probably not  the                                                                    
1:49:56 PM                                                                                                                    
CHAIR WILSON opened public testimony on SB 20.                                                                                  
1:50:08 PM                                                                                                                    
KATE  BURKHART, Executive  Director, Alaska  Mental Health  Board                                                               
and  Advisory   Board  on  Alcoholism  and   Drug  Abuse,  Alaska                                                               
Department  of  Health  and   Social  Services,  Juneau,  Alaska,                                                               
addressed  recommendations from  the  Alaska  Opioid Policy  Task                                                               
Force as follows:                                                                                                               
     Given that your conversation  has moved toward the idea                                                                    
     of how  can we  be more  nimble in  addressing emerging                                                                    
     public  health dangers  such as  synthetic opioids  and                                                                    
     other synthetic substances of abuse,  I would be remise                                                                    
     if I  did not mention  that one of  the recommendations                                                                    
     of the  Alaska Opioid  Policy Task  Force; which  was a                                                                    
     joint  effort of  the Division  of  Public Health,  the                                                                    
     Advisory  Board  on  Alcoholism  and  Drug  Abuse,  the                                                                    
     Alaska  Mental  Health  Trust  Authority,  and  Senator                                                                    
     Giessel participated.  One of those  recommendations is                                                                    
     to provide  for a  mechanism like Dr.  Butler described                                                                    
     that  the   U.S.  Drug  Enforcement  Agency   uses  for                                                                    
     emergency regulatory  action when there is  an emerging                                                                    
     public health  danger posed by  some sort  of synthetic                                                                    
     substance.  We don't  have that  ability  right now  in                                                                    
     Alaska, so we rely  on proactive legislators to address                                                                    
     those    concerns,   but    there   is    a   consensus                                                                    
     recommendation  from  the  Alaska  Opioid  Policy  Task                                                                    
     Force that this would be a  way that we could pounce on                                                                    
     things earlier rather than  waiting until January every                                                                    
     year  to get  ahead of  those  things and  to give  law                                                                    
     enforcement the tools they need  to move forward. Given                                                                    
     that I had the opportunity  to work with the task force                                                                    
     I felt like  we just put that into the  universe, it is                                                                    
     not a  recommendation related to  this bill at  all, we                                                                    
     appreciate the  bill, but  since your  conversation led                                                                    
     there I thought I would add that to the mix.                                                                               
1:52:38 PM                                                                                                                    
CHAIR WILSON closed public testimony on SB 20.                                                                                  
1:52:57 PM                                                                                                                    
SENATOR GIESSEL moved Amendment 1.                                                                                              
                          AMENDMENT 1                                                                                         
     OFFERED IN THE SENATE                                                                                                      
     TO: SB 20                                                                                                                  
     Page 1, line 1, following "substance;":                                                                                    
     Insert "classifying tramadol  and related substances as                                                                    
     schedule IVA controlled substances;"                                                                                       
     Page 4, following line 29:                                                                                                 
     Insert a new bill section to read:                                                                                         
     "Sec.  2.  AS 11.71.170  is  amended  by adding  a  new                                                                    
     subsection to read:                                                                                                        
     (g)   Schedule   IVA  includes,   unless   specifically                                                                    
     excepted  or unless  listed  in  another schedule,  any                                                                    
     material,  compound,  mixture,   or  preparation  which                                                                    
     contains  any quantity  of the  following substance  or                                                                    
     its  salts calculated  as the  free  anhydrous base  or                                                                    
     alkaloid:               2-[(dimethylamino)methyl]-1-(3-                                                                    
     methoxyphenyl)cyclohexanol,  its   salts,  optical  and                                                                    
     geometric   isomers,  and   salts  of   these  isomers,                                                                    
     including tramadol."                                                                                                       
     Renumber the following bill section accordingly.                                                                           
1:53:11 PM                                                                                                                    
At ease.                                                                                                                        
1:54:20 PM                                                                                                                    
CHAIR WILSON  called the  committee back  to order.  He announced                                                               
that before taking  up the amendment, Ms. Marasigan  has asked to                                                               
address earlier questions from committee members.                                                                               
MS.   MARASIGAN  noted   a   previous   inquiry  about   chemical                                                               
composition  "wiggle  room"  on   deciding  whether  a  specified                                                               
material is a Schedule I drug.  She revealed that Section 1 in SB
20  covers  opiates and  opiate  variants:  isomers, esters,  and                                                               
She addressed  a more nimble  regulatory process query  and noted                                                               
that some  states have an  emergency-regulatory board  that enact                                                               
emergency-schedule materials until  the next legislative session.                                                               
She added that fast-track legislation  is a similar consideration                                                               
where  substance-abuse  advisory  boards  are  involved  until  a                                                               
legislature catches up.                                                                                                         
She  cautioned  on  the  danger  of putting  a  material  on  the                                                               
controlled substance  list without testimony and  public input in                                                               
order to avoid  putting something on the list that  does not need                                                               
to be there.                                                                                                                    
SENATOR MICCICHE  stated that he heeded  Ms. Marasigan's warning,                                                               
but pointed out that the  Legislature finally addressed the Spice                                                               
issue  saying  that  anything  within  set  parameters  would  be                                                               
regarded  as a  synthetic  drug  that is  illegal  in Alaska.  He                                                               
opined that  a balance probably  exists to put  parameters around                                                               
the  ability to  create emergency  authority to  see if  there is                                                               
something in  between that  might be more  effective. He  said he                                                               
would work with Senator Meyer  should he consider an amendment to                                                               
the bill.                                                                                                                       
1:57:50 PM                                                                                                                    
SENATOR MEYER pointed out that  Spice, the synthetic cannabinoid,                                                               
was a  little easier  to deal with  because the  Legislature went                                                               
after the packaging  of something that was being  sold as incense                                                               
that  obviously had  nothing to  do with  incense. He  noted that                                                               
bath salts presented  a similar situation, but  conceded that the                                                               
problem  has  gone from  synthetic  cocaine  from bath  salts  to                                                               
heroin, which is worse. He  agreed with Ms. Marasigan that making                                                               
something a  crime warrants a  deliberate process. He  said there                                                               
is probably  a better way and  he is open to  any suggestions the                                                               
committee may have.                                                                                                             
CHAIR  WILSON  asked  Captain Duxbury  from  the  Statewide  Drug                                                               
Enforcement  Unit   for  his  comments   on  some  of   the  drug                                                               
enforcement issues, challenges or successes.                                                                                    
1:59:48 PM                                                                                                                    
MICHAEL  DUXBURY,  Captain,   Statewide  Drug  Enforcement  Unit,                                                               
Alaska  State  Troopers,  Anchorage,  Alaska,  addressed  federal                                                               
spending and explained that federal  scheduling has minimums that                                                               
are quite high for Alaska; however,  the state is affected due to                                                               
its small population with a  wide distribution area. He explained                                                               
that Alaska needed  the ability to perform  operations that could                                                               
target some  of the issues going  with Pink or U-47700.  He noted                                                               
that  another  dynamic  is  that   Pink  or  U-47700  is  readily                                                               
available on the internet and  certain types of retail outlets in                                                               
Alaska. He  asserted that the  drug's ability to have  a negative                                                               
impact on  the state  is significant and  even small  amounts are                                                               
worth the  Statewide Drug  Enforcement Unit  to pay  attention to                                                               
the drug because of its lethality.                                                                                              
He disclosed  that he had  discussions with an expert  chemist as                                                               
well  as   a  Drug   Enforcement  Administration   (DEA)  chemist                                                               
regarding  coverage of  isomers, salts  and esters.  He disclosed                                                               
that the  chemists believed that  the state's attempt would  be a                                                               
pretty  good  attempt;  however,  not  all  situations  would  be                                                               
2:02:43 PM                                                                                                                    
SENATOR  MICCICHE  remarked  that  Alaska is  seeing  a  dramatic                                                               
explosion in  heroine, synthetic opioid, and  prescription opioid                                                               
distribution and  abuse. He noted  that the drugs can  my ordered                                                               
online  and asked  if  the  department has  an  effective way  to                                                               
interrupt the flow into Alaska.                                                                                                 
CAPTAIN  DUXBURY concurred  that the  situation Senator  Micciche                                                               
addressed is  a tremendous  problem. He said  the state  is being                                                               
exploited  by individuals  that  realize  illicit substances  can                                                               
bring up  to three times more  money in Alaska. He  revealed that                                                               
organized-crime  gangs  from  the  Lower 48  are  exploiting  the                                                               
state's vulnerable  communities. He  detailed that  the Statewide                                                               
Drug Enforcement Unit  is concentrating on those  places that are                                                               
"hubs" in  the state. He  said due to budgetary  constraints, the                                                               
unit  does not  have the  resources  for a  broader approach.  He                                                               
disclosed that  in order to  deal with its  resource constraints,                                                               
the unit tries to find  collaborative and cooperative partners in                                                               
any and  every avenue. He  asserted that the state  cannot arrest                                                               
its way  out of  the problem.  He said  as much  as the  need for                                                               
enforcement,  the  state  has  to  have  social  and  educational                                                               
programs in addition to more deterrence for consumption.                                                                        
SENATOR  BEGICH  said  he  recognized  the  prevention  end  that                                                               
Captain  Duxbury noted,  but wondered  if a  more nimble  process                                                               
from emergency regulation would help  the enforcement end for the                                                               
Statewide Drug Enforcement Unit.                                                                                                
CAPTAIN DUXBURY replied yes.                                                                                                    
2:05:50 PM                                                                                                                    
SENATOR  MEYER remarked  that  he is  very  frustrated about  the                                                               
topic  and believes  everybody is  as well.  He noted  that drug-                                                               
related crimes are prevalent throughout  Alaska on a daily basis.                                                               
He concurred with  Senator Micciche that the demand  is out there                                                               
for synthetic drugs, heroine, or  prescription drugs. He remarked                                                               
that as  long as the  demand for drugs  is out there,  people are                                                               
going to  provide it and the  state will have an  ongoing problem                                                               
with public safety, judiciary, and  trying to fight it. He opined                                                               
that  the  state can  build  more  treatment and  rehab  centers;                                                               
however,  they only  help people  who want  help. He  said he  is                                                               
frustrated on how to reduce the  demand for drugs and thinks that                                                               
better education and keeping topics  like what the bill addresses                                                               
out in the forefront to the public is needed.                                                                                   
CHAIR WILSON asked that Senator Giessel address Amendment 1.                                                                    
2:07:45 PM                                                                                                                    
SENATOR  GIESSEL reintroduced  Amendment 1,  [30-LS0319\A.1]. She                                                               
stated that the  issue that is illuminated in SB  20 is extremely                                                               
important.  She said  as a  side  comment, Ms.  Burkhart and  Dr.                                                               
Butler have  both eluded to  the Alaska Opioid Policy  Task Force                                                               
and  asserted that  the  committee would  find  the task  force's                                                               
recommendations  very interesting.  She said  the recommendations                                                               
certainly apply to content of SB  20, but also apply to Amendment                                                               
1. She detailed that Amendment  1 would move tramadol [to another                                                               
drug schedule.]                                                                                                                 
CHAIR WILSON asked if there was an objection to Amendment 1.                                                                    
SENATOR GIESSEL  objected for  discussion purposes.  She detailed                                                               
that Amendment 1 would place  tramadol as Schedule IVA controlled                                                               
substance in  Alaska statute. She  explained the reasons  for the                                                               
schedule change as follows:                                                                                                     
   · DEA placed tramadol on Schedule IV in 2014.                                                                                
   · Tramadol is an "analgesic" opioid-like drug that is used to                                                                
     relieve pain.                                                                                                              
   · Tramadol has shown to cause serious side effects and be                                                                    
   · Other countries and states in the U.S. have classified                                                                     
     tramadol as a controlled substance.                                                                                        
   · Health-care   professionals   have   provided   letters   of                                                               
     recommendations to place tramadol on the Schedule IV                                                                       
     substance list.                                                                                                            
   · Tramadol would be placed on the state's prescription-drug                                                                  
     monitoring system to identify potentials for abuse.                                                                        
SENATOR  GIESSEL detailed  that lines  2 and  3 in  the amendment                                                               
would bring  forth an addition to  the title of the  bill because                                                               
the change  is not  a Schedule  I, but a  Schedule IV.  She added                                                               
that lines 8-12  is a new subsection that would  list tramadol in                                                               
state statute.                                                                                                                  
SENATOR MICCICHE  asked for  additional information  on tramadol,                                                               
specifically about its abuse.                                                                                                   
2:11:58 PM                                                                                                                    
SENATOR  GIESSEL detailed  that in  2010 there  were more  16,000                                                               
visits  to emergency  rooms in  the U.S.  that resulted  from the                                                               
non-medical  use  of  tramadol.   She  added  that  tramadol  has                                                               
significant  withdrawal   side  effects  that  could   result  in                                                               
emergency-room visits.                                                                                                          
CHAIR  WILSON  asked  if anyone  had  additional  information  on                                                               
tramadol that could be shared with committee members.                                                                           
CAPTAIN  DUXBURY   addressed  western   Alaska  and   noted  that                                                               
investigators have  seen a significant  amount of  tramadol being                                                               
sold for approximately $2.00 to  $2.50 per milligram. He detailed                                                               
that there have  been 11 incidences of capturing  tramadol in hub                                                               
locations  where   6,000  dosage  units  were   seized  prior  to                                                               
distribution  to villages.  He concurred  with Senator  Giessel's                                                               
previous  comments  that  tramadol  has an  overdose  effect.  He                                                               
revealed  that tramadol  has been  substituted  when opioids  are                                                               
hard to obtain. He emphasized that  tramadol is being abused on a                                                               
regular basis.                                                                                                                  
2:14:30 PM                                                                                                                    
DR. BUTLER  added that  tramadol has a  "double whammy"  where an                                                               
opioid-type   effect   is   caused  that   includes   respiratory                                                               
depression,  toxicity  on  the liver  such  that  people  develop                                                               
extremely low blood sugar, and seizures.                                                                                        
SENATOR BEGICH asked Dr. Butler if he supported Amendment 1.                                                                    
DR. BUTLER answered yes.                                                                                                        
SENATOR GIESSEL removed her objection to Amendment 1.                                                                           
CHAIR  WILSON announced  that without  objection, Amendment  1 is                                                               
2:16:06 PM                                                                                                                    
CHAIR  WILSON  stated  he  would  hold SB  20  in  committee.  He                                                               
announced that a  committee substitute will be  introduced at the                                                               
next committee meeting.                                                                                                         
SENATOR  BEGICH  asked if  other  committee  members intended  to                                                               
present  an amendment  related to  "regulatory" because  he would                                                               
support an amendment or a separate piece of legislation.                                                                        
SENATOR   MICCICHE   explained   that    he   will   do   further                                                               
investigation. He stated  that his intent is to  be effective and                                                               
make the right choice.                                                                                                          
He said  he had  another question for  Captain Duxbury  and asked                                                               
what  detection  methods  are   used  for  drug  trafficking.  He                                                               
inquired if  dogs were  used for drug  detection. He  opined that                                                               
the  constitution will  sometimes  get in  the  way of  effective                                                               
drug-trafficking management.  He lauded  Captain Duxbury  for his                                                               
hard  work, but  conceded  that  the state  is  currently in  the                                                               
"losing column."                                                                                                                
2:18:01 PM                                                                                                                    
CAPTAIN DUXBURY  revealed that  canine-scent detection  teams are                                                               
not  trained  for  tramadol.   He  addressed  Senator  Micciche's                                                               
comment regarding  being in  the "losing  column" and  noted that                                                               
the number of  people in the Statewide Drug  Enforcement Unit are                                                               
a fraction  of what he  was used  when he started.  He reiterated                                                               
that the state cannot arrest its  way out of its drug problem. He                                                               
thanked Dr.  Butler for his  service on the Alaska  Opioid Policy                                                               
Task  Force and  reiterated that  collaboration is  the only  way                                                               
under the current  budget constraints to able to make  a dent. He                                                               
noted that the  state has some finite  drug-transport conduits as                                                               
opposed to the Lower 48 and  the unit tries to work together with                                                               
the Department of Transportation and commercial airlines.                                                                       
SENATOR GIESSEL  remarked that  the discussion  around SB  20 and                                                               
the expert testimony highlighted how  important the subject is to                                                               
committee members.  She reiterated  that having Ms.  Burkhart and                                                               
Dr. Butler back  before the committee to address  what the Alaska                                                               
Opioid  Policy Task  Force  did during  the  previous summer  was                                                               
important. She  noted that Senator  Meyer brought up the  idea of                                                               
prevention  and revealed  that prevention  was an  aspect of  the                                                               
discussions that  the task force  addressed as well.  She pointed                                                               
out  that  Alaska  is  number one  in  substance  abuse,  alcohol                                                               
substances,  and  behavioral  health   issues.  She  opined  that                                                               
committee  members   would  have  a   lot  of  great   ideas  for                                                               
legislation after hearing the report  of the Alaska Opioid Policy                                                               
Task Force.                                                                                                                     
CHAIR  WILSON agreed  with  Senator Giessel.  He  noted that  the                                                               
committee will  hear an overview  on the science of  addiction at                                                               
an  upcoming  meeting  to  start   the  discussion  for  positive                                                               
solutions regarding  opioid and  other types of  addiction issues                                                               
that are facing the state.                                                                                                      
[SB 20 was held in committee.]                                                                                                  

Document Name Date/Time Subjects
SB 20 Version A.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
SB 20 Bill Hearing Request Memo SHSS.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
SB 20 Sponsor Statement Version A.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
Fiscal Notes SB 20.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
SB 20 Support Material Federal Register DEA-440.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
SB 20 Letter of Support DPoL Attorney General.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
SB 20 Letter of Support ABADA AMHB Executive Director.pdf SHSS 2/8/2017 1:30:00 PM
SB 20
SB 20 Letter of Support DHSS Chief Medical Officer.pdf SHSS 2/8/2017 1:30:00 PM
SB 20